GDF15 and peripheral arterial disease: We aimed to evaluate how the relative plasma concentrations of NT-proBNP and GDF-15 obtained with the PEA correlate with the absolute plasma concentrations obtained with a conventional assay in individuals with and without verified manifest peripheral arterial disease (PAD).